Department of Radiology, the Affiliated Hospital of Guizhou Medical University. Guiyang, China.
Department of Medical Insurance, the Affiliated Hospital of Guizhou Medical University, Guiyang, China.
J Xray Sci Technol. 2020;28(3):369-381. doi: 10.3233/XST-200670.
To evaluate the clinical and computed tomographic (CT) features in the patients with COVID-19 pneumonia confirmed by the real-time reverse transcriptase polymerase chain reaction (rRT-PCR) amplification of the viral DNA from a sputum sample.
Clinical information and CT findings of a total of 14 patients with COVID-19 infection (age range, 12-83 years; females 6) were analyzed retrospectively. The clinical information includes the history of exposure, laboratory results, and the symptoms (such as fever, cough, headache, etc.); CT findings of chest include the extension and distribution of lesion, the ground-glass opacity (GGO), consolidation, bronchovascular enlarged, irregular linear appearances, pleural effusion, and lymphadenopathy.
Eight patients had the exposure history for recent travel to Wuhan of Hubei province (8/14, 57%), 6 had the exposure to patients with COVID-19 infection. Significant statistical differences were observed in lymphocyte percentage decreased and C-reactive protein elevated (p = 0.015). Seven patients had fever, 7 had cough, 2 had headache, 3 had fatigue, 1 had body soreness, 3 had diarrhea, and 2 had no obvious symptoms. In chest CT examination, 10 patients were positive (10/14, 71.43%). Among these patients, 9 had lesions involving both lungs (9/10, 90%), 8 had lesions involving 4 to 5 lobes (8/10, 80%). Most of lesions were distributed peripherally and the most significant lesions were observed in the right lower lobe in 9 patients (9/10, 90%). Nodules were observed in 5 patients (5/10, 50%); GGO, consolidation, and bronchovascular enlarged were shown in 9 patients (9/10, 90%); irregular linear appearances were revealed in 7 patients (7/10, 70%); and pleural effusions were exhibited in 2 patients (2/10, 20%). Last, no patients showed lymphadenopathy.
There were some typical CT features for diagnosis of COVID-19 pneumonia. The radiologists should know these CT findings and clinical information, which could help for accurate analysis in the patients with 2019 novel coronavirus infection.
评估通过实时逆转录聚合酶链反应(rRT-PCR)扩增病毒 DNA 从痰样本中检测到的新型冠状病毒肺炎(COVID-19)患者的临床和计算机断层扫描(CT)特征。
回顾性分析了 14 例经病毒 DNA 实时 rRT-PCR 扩增确诊的 COVID-19 感染患者的临床资料和 CT 表现(年龄 12-83 岁,女性 6 例)。临床资料包括接触史、实验室结果和症状(如发热、咳嗽、头痛等);胸部 CT 表现包括病变的范围和分布、磨玻璃密度影(GGO)、实变、支气管血管增粗、不规则线状影、胸腔积液和淋巴结肿大。
8 例(8/14,57%)有近期前往湖北省武汉市的旅行史,6 例有 COVID-19 感染患者的接触史。淋巴细胞百分比下降和 C 反应蛋白升高有显著统计学差异(p=0.015)。7 例发热,7 例咳嗽,2 例头痛,3 例乏力,1 例全身酸痛,3 例腹泻,2 例无明显症状。胸部 CT 检查 10 例阳性(10/14,71.43%)。其中 9 例病变累及双肺(9/10,90%),8 例病变累及 4-5 个肺叶(8/10,80%)。病变多位于外周,9 例(9/10,90%)右肺下叶病变最明显。5 例(5/10,50%)可见结节,9 例(9/10,90%)可见磨玻璃影、实变和支气管血管增粗,7 例(7/10,70%)可见不规则线状影,2 例(2/10,20%)可见胸腔积液。最后,无患者出现淋巴结肿大。
COVID-19 肺炎有一些典型的 CT 特征。放射科医生应了解这些 CT 表现和临床信息,这有助于对 2019 年新型冠状病毒感染患者进行准确分析。